Herlyn D - Search Results

1

Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptor.

Derui L, Woo DV, Emrich J, Steplewski Z, Rodeck U, Herlyn D, Koprowski H, Miyamoto C, Brady LW. Derui L, et al. Among authors: herlyn d. Am J Clin Oncol. 1992 Aug;15(4):288-94. doi: 10.1097/00000421-199208000-00003. Am J Clin Oncol. 1992. PMID: 1514524 No abstract available.

2

Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha.

Adachi K, Belser P, Bender H, Li D, Rodeck U, Benveniste EN, Woo D, Schmiegel WH, Herlyn D. Adachi K, et al. Among authors: herlyn d. Cancer Immunol Immunother. 1992;34(6):370-6. doi: 10.1007/BF01741746. Cancer Immunol Immunother. 1992. PMID: 1563013 Free PMC article.

3

Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor.

Bender H, Takahashi H, Adachi K, Belser P, Liang SH, Prewett M, Schrappe M, Sutter A, Rodeck U, Herlyn D. Bender H, et al. Among authors: herlyn d. Cancer Res. 1992 Jan 1;52(1):121-6. Cancer Res. 1992. PMID: 1727372

4

Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma.

Herlyn D, Sears HF, Ernst CS, Iliopoulos D, Steplewski Z, Koprowski H. Herlyn D, et al. Am J Clin Oncol. 1991 Oct;14(5):371-8. doi: 10.1097/00000421-199110000-00002. Am J Clin Oncol. 1991. PMID: 1951172 Clinical Trial.

5

Monoclonal antibodies as applied to tumor-associated antigens: the CO17-1A antigen.

Ross AH, Herlyn D, Steplewski Z, Koprowski H. Ross AH, et al. Among authors: herlyn d. Immunol Ser. 1989;43:107-22. Immunol Ser. 1989. PMID: 2490493 Review.

6

Monoclonal antibodies with cytotoxic reactivities against human gliomas.

Nanda A, Liwnicz B, Atkinson BF, Sela BA, Takahashi H, Belser PH, Black P, Koprowski H, Herlyn D. Nanda A, et al. Among authors: herlyn d. J Neurosurg. 1989 Dec;71(6):892-7. doi: 10.3171/jns.1989.71.6.0892. J Neurosurg. 1989. PMID: 2585082

7

Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides.

Iliopoulos D, Ernst C, Steplewski Z, Jambrosic JA, Rodeck U, Herlyn M, Clark WH Jr, Koprowski H, Herlyn D. Iliopoulos D, et al. Among authors: herlyn d, herlyn m. J Natl Cancer Inst. 1989 Mar 15;81(6):440-4. doi: 10.1093/jnci/81.6.440. J Natl Cancer Inst. 1989. PMID: 2918552

8

Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.

Rodeck U, Herlyn M, Herlyn D, Molthoff C, Atkinson B, Varello M, Steplewski Z, Koprowski H. Rodeck U, et al. Among authors: herlyn d, herlyn m. Cancer Res. 1987 Jul 15;47(14):3692-6. Cancer Res. 1987. PMID: 3297307

9

Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor.

Takahashi H, Herlyn D, Atkinson B, Powe J, Rodeck U, Alavi A, Bruce DA, Koprowski H. Takahashi H, et al. Among authors: herlyn d. Cancer Res. 1987 Jul 15;47(14):3847-50. Cancer Res. 1987. PMID: 3594441

10

Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas.

Takahashi H, Belser PH, Atkinson BF, Sela BA, Ross AH, Biegel J, Emanuel B, Sutton L, Koprowski H, Herlyn D. Takahashi H, et al. Among authors: herlyn d. Neurosurgery. 1990 Jul;27(1):97-102. doi: 10.1097/00006123-199007000-00013. Neurosurgery. 1990. PMID: 1695996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters